"Political fundraiser" has a fancy ring to it — tuxedos, famous singers, billionaires. In fact, most political fundraisers aren't that glamorous.
Think instead of a dozen lobbyists eating breakfast with a Congressman in a side room at some DC restaurant. Off in a corner, someone who works for the Congressman is holding the checks the lobbyists brought to get in the door.
Another batch of phony cancer drugs has made its way into the U.S., the Food and Drug Administration says.
U.S.-based medical practices purchased vials of counterfeit medicine labeled as Altuzan from a foreign supplier, FDA spokesperson Shelly Burgess tells Shots. She said the agency doesn't have any reports of patients having received the counterfeit drugs.
Altuzan is the Turkish brand name for Avastin, the FDA-approved blockbuster cancer drug from Swiss drugmaker Roche's Genentech unit. Altuzan is approved for use in Turkey — but not in the U.S.
The peace plan brokered by international envoy Kofi Annan and backed the United Nations has yet to curb the violence in Syria.
Reuters reports that even though a U.N. team of peacekeepers is scheduled to arrive in Damascus, today or tomorrow, opposition activists said government forces continued their attack. They said about 80 people have been killed since Tuesday.
Italy's technocrat prime minister, Mario Monti, came to office less than five months ago as the country's finances were in a tailspin. And now he could be facing his toughest challenge yet — pushing through changes to labor regulations.
Italian labor rules ensure job security for older workers but can condemn the younger generation to a series of insecure, temporary jobs.
Since taking office, Monti has pushed through a round of tough austerity measures, budget cuts, pension reform and some deregulation.